Higgins John L
- SEC CIK
- 0001208906
In the past year, 1 open-market purchase filing worth $107.7K and no sales.
Current role at each company
- OABI OmniAb, Inc.Directoras of Jun 18, 2026
- TECH BIO-TECHNE CorpDirectoras of Nov 3, 2025
- LGND Ligand Pharmaceuticals IncDirectoras of Dec 30, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $107.7K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$107.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Higgins John L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OABI OmniAb, Inc.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2023 (view filing) | May 18 | 1 day | Higgins John LDirector | SSale | −50.0K | $3.89 | −$194.5K | −2.0%2.46M after | |
| May 23, 2023 (view filing) | May 19 | 4 days | Higgins John LDirector | SSale | −1.00K | $4.05 | −$4.05K | 0.0%2.46M after | |
| May 25, 2023 (view filing) | May 23 | 2 days | Higgins John LDirector | SSale | −9.00K | $4.05 | −$36.5K | −0.4%2.46M after | |
| Mar 20, 2025 (view filing) | Mar 20 | Same day | Higgins John LDirector | PPurchase | +125.8K | $2.35 | +$295.5K | +4.8%2.76M after | |
| Mar 21, 2025 (view filing) | Mar 21 | Same day | Higgins John LDirector | PPurchase | +4.00K | $2.28 | +$9.12K | +0.1%2.77M after | |
| May 13, 2025 (view filing) | May 12 | 1 day | Higgins John LDirector | PPurchase | +65.0K | $1.44 | +$93.6K | +2.3%2.83M after | |
| Nov 10, 2025 (view filing) | Nov 6-7 | 4 days | Higgins John LDirector | PPurchase | +77.3K | $1.39 | +$107.7K | +2.7%2.93M after | 2 lots |
TECH BIO-TECHNE Corp
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2022 (view filing) | Jun 7-8 | 2 days | Higgins John LDirector | SSale | −1.60K | $364.98 | −$584.0K | −25.8%4.61K after | 2 lots |
| Aug 12, 2022 (view filing) | Aug 10-11 | 2 days | Higgins John LDirector | SSale | −2.50K | $378.80 | −$948.5K | −31.3%5.50K after | 5 lots |
| May 16, 2024 (view filing) | May 14 | 2 days | Higgins John LDirector | SSale | −4.00K | $83.84 | −$335.4K | −9.9%36.6K after |
LGND Ligand Pharmaceuticals Inc
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2021 (view filing) | Nov 12 | Same day | Higgins John LChief Executive Officer | SSale | −3.00K | $160.50 | −$481.5K | −0.9%335.1K after | |
| May 10, 2022 (view filing)5:33 PM ET | May 10 | Same day | Higgins John LChief Executive Officer | SSale0.75% Convertible Senior Notes due 2023 | – | – | – | – | DerivativePrice outlier |
| Sep 16, 2022 (view filing) | Sep 15 | 1 day | Higgins John LChief Executive Officer | SSale | −2.00K | $90.00 | −$180.0K | −0.5%367.2K after | From original |
| Sep 22, 2022 (view filing) | Sep 16 | 6 days | Higgins John LChief Executive Officer | SSale | −1.00K | $88.06 | −$88.1K | −0.3%366.2K after | Amended |
| Nov 21, 2022 (view filing) | Nov 17 | 4 days | Higgins John LChief Executive Officer | SSale | −10.0K | $78.32 | −$783.2K | −2.3%416.7K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Higgins John LDirector | SSale | −10.0K | $61.87 | −$618.7K | −2.3%423.0K after |